Management of Gram-Positive Cocci Infections

Initial Empirical Treatment

• The Infectious Diseases Society of America recommends starting empirical vancomycin 15-20 mg/kg IV every 8-12 hours immediately while awaiting final culture identification and susceptibility results 1, 2
• Obtain at least two sets of blood cultures from separate sites before initiating antibiotics whenever clinically feasible, as recommended by the Clinical Infectious Diseases guidelines 3, 1, 2

Risk Assessment and Antibiotic Modification

• The American College of Physicians suggests adding vancomycin to the initial regimen if factors such as hemodynamic instability, suspected catheter-related infection, or known MRSA colonization are present 3, 5, 6
• For Methicillin-Susceptible S. aureus (MSSA), switch to nafcillin, oxacillin, or cefazolin as these beta-lactams are superior to vancomycin, according to the Praxis Medical Insights guidelines 1, 2

Duration of Therapy and Monitoring

• The Clinical Infectious Diseases guidelines recommend 2 weeks of therapy from the first negative blood culture for uncomplicated bacteremia, and 4-6 weeks for complicated bacteremia 1, 2
• Repeat blood cultures daily until sterile to document clearance, and monitor vancomycin trough levels before the 4th dose, targeting 15-20 mg/L for serious S. aureus infections 1, 2

Source Control and Common Pitfalls

• Remove intravascular catheters for S. aureus bacteremia unless absolutely necessary, and drain abscesses and debride necrotic tissue as antibiotics alone are insufficient for localized purulent collections 5, 2, 8, 7
• Do not delay vancomycin while awaiting culture results in critically ill patients, and do not continue vancomycin for MSSA - beta-lactams have superior efficacy and should be used once susceptibility is confirmed 3, 6, 1, 2